Shenzhen FRD Science & Technology's (SZSE:300602) Earnings Have Declined Over Five Years, Contributing to Shareholders 9.9% Loss
Shenzhen FRD Science & Technology's (SZSE:300602) Earnings Have Declined Over Five Years, Contributing to Shareholders 9.9% Loss
Over the last month the Shenzhen FRD Science & Technology Co., Ltd. (SZSE:300602) has been much stronger than before, rebounding by 49%. But that doesn't change the fact that the returns over the last five years have been less than pleasing. You would have done a lot better buying an index fund, since the stock has dropped 11% in that half decade.
上個月,深圳富力達科技股份有限公司(深交所股票代碼:300602)比以前強勁得多,反彈了49%。但這並不能改變這樣一個事實,即過去五年的回報並不令人滿意。購買指數基金的表現要好得多,因爲該股在那五年中下跌了11%。
Although the past week has been more reassuring for shareholders, they're still in the red over the last five years, so let's see if the underlying business has been responsible for the decline.
儘管過去一週令股東更加放心,但在過去五年中,他們仍處於虧損狀態,所以讓我們看看基礎業務是否是造成下降的原因。
To paraphrase Benjamin Graham: Over the short term the market is a voting machine, but over the long term it's a weighing machine. One way to examine how market sentiment has changed over time is to look at the interaction between a company's share price and its earnings per share (EPS).
用本傑明·格雷厄姆的話來說:從短期來看,市場是一臺投票機器,但從長遠來看,它是一臺稱重機。研究市場情緒如何隨着時間的推移而變化的一種方法是研究公司股價與其每股收益(EPS)之間的相互作用。
Shenzhen FRD Science & Technology became profitable within the last five years. Most would consider that to be a good thing, so it's counter-intuitive to see the share price declining. Other metrics might give us a better handle on how its value is changing over time.
深圳FRD科技在過去五年中實現了盈利。大多數人會認爲這是一件好事,因此股價下跌是違反直覺的。其他指標可能會讓我們更好地了解其價值如何隨着時間的推移而變化。
In contrast to the share price, revenue has actually increased by 20% a year in the five year period. So it seems one might have to take closer look at the fundamentals to understand why the share price languishes. After all, there may be an opportunity.
與股價形成鮮明對比的是,在五年期間,收入實際上每年增長20%。因此,看來人們可能必須仔細研究基本面才能理解股價下跌的原因。畢竟,可能有機會。
You can see how earnings and revenue have changed over time in the image below (click on the chart to see the exact values).
您可以在下圖中看到收入和收入隨時間推移而發生的變化(點擊圖表查看確切值)。
![earnings-and-revenue-growth](https://usnewsfile.moomoo.com/public/MM-PersistNewsContentImage/7781/20240312/0-e276e2f59d1536f7509e7214ea24611f-0-5b68cc43ffa2336b9a4f5811202d07a9.png/big)
We know that Shenzhen FRD Science & Technology has improved its bottom line lately, but what does the future have in store? You can see what analysts are predicting for Shenzhen FRD Science & Technology in this interactive graph of future profit estimates.
我們知道深圳FRD科技最近提高了利潤,但是未來會發生什麼呢?在這張未來利潤估計的交互式圖表中,您可以看到分析師對深圳FRD科技的預測。
A Different Perspective
不同的視角
It's good to see that Shenzhen FRD Science & Technology has rewarded shareholders with a total shareholder return of 6.9% in the last twelve months. There's no doubt those recent returns are much better than the TSR loss of 1.9% per year over five years. The long term loss makes us cautious, but the short term TSR gain certainly hints at a brighter future. I find it very interesting to look at share price over the long term as a proxy for business performance. But to truly gain insight, we need to consider other information, too. Consider for instance, the ever-present spectre of investment risk. We've identified 3 warning signs with Shenzhen FRD Science & Technology , and understanding them should be part of your investment process.
很高興看到深圳富力達科技在過去十二個月中向股東提供了6.9%的總股東回報率。毫無疑問,最近的回報遠好於五年內股東總回報率每年1.9%的虧損。長期虧損使我們保持謹慎,但短期股東總回報率的增長無疑暗示着更光明的未來。我發現將長期股價視爲業務績效的代表非常有趣。但是,要真正獲得見解,我們還需要考慮其他信息。例如,投資風險的幽靈無處不在。我們已經確定了深圳FRD科技的3個警告信號,了解它們應該是您投資過程的一部分。
If you like to buy stocks alongside management, then you might just love this free list of companies. (Hint: insiders have been buying them).
如果你想與管理層一起購買股票,那麼你可能會喜歡這份免費的公司名單。(提示:業內人士一直在購買它們)。
Please note, the market returns quoted in this article reflect the market weighted average returns of stocks that currently trade on Chinese exchanges.
請注意,本文引用的市場回報反映了目前在中國交易所交易的股票的市場加權平均回報。
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
對這篇文章有反饋嗎?對內容感到擔憂?直接聯繫我們。 或者,給編輯團隊 (at) simplywallst.com 發送電子郵件。
Simply Wall St的這篇文章本質上是籠統的。我們僅使用公正的方法根據歷史數據和分析師的預測提供評論,我們的文章無意作爲財務建議。它不構成買入或賣出任何股票的建議,也沒有考慮到您的目標或財務狀況。我們的目標是爲您提供由基本數據驅動的長期重點分析。請注意,我們的分析可能不考慮最新的價格敏感型公司公告或定性材料。簡而言之,華爾街沒有持有任何上述股票的頭寸。